
|Videos|March 31, 2021
Dr. Leonard Gomella on unanswered questions with biomarkers in prostate cancer
Author(s)Urology Times staff
Leonard G. Gomella, MD, discusses questions that still need to be resolved with biomarkers for the diagnosis and management of patients with prostate cancer.
Advertisement
Leonard G. Gomella, MD, chairman of the Department of Urology at the Sidney Kimmel Cancer Center, discusses questions that still need to be resolved with biomarkers for the diagnosis and management of patients with prostate cancer.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA provides guidance on development pathway for testosterone therapy for women
2
Pearls & Perspectives: Leadership and Prostate Cancer, with Mark L. Gonzalgo, MD, PhD, MBA
3
Pedro Freitas, MD, on consolidative surgery vs prolonged systemic therapy in MIBC
4
Treatment Selection in Advanced Prostate Cancer
5






